Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$1.6 million.

  • Firefly Neuroscience's Free Cash Flow rose 3761.4% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year decrease of 4128.74%. This contributed to the annual value of -$6.3 million for FY2024, which is 19019.34% down from last year.
  • Latest data reveals that Firefly Neuroscience reported Free Cash Flow of -$1.6 million as of Q3 2025, which was up 3761.4% from -$2.4 million recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Free Cash Flow high stood at $491536.0 for Q3 2023, and its period low was -$2.9 million during Q4 2022.
  • Over the past 5 years, Firefly Neuroscience's median Free Cash Flow value was -$1.3 million (recorded in 2024), while the average stood at -$1.3 million.
  • Per our database at Business Quant, Firefly Neuroscience's Free Cash Flow soared by 15486.69% in 2021 and then crashed by 133797.73% in 2022.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Free Cash Flow stood at -$322949.0 in 2021, then crashed by 793.73% to -$2.9 million in 2022, then skyrocketed by 82.33% to -$510000.0 in 2023, then crashed by 154.51% to -$1.3 million in 2024, then decreased by 21.26% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$2.4 million for Q2 2025, and -$2.5 million during Q1 2025.